Press Releases
-
Parenteral Drug Association and Euromed Communications Release Second Co-published book, Industrial Pharmaceutical Microbiology: Quality Control
The new title is co-edited by Edward C. Tidswell, Merck Exec. Dir. Of Sterile and Micro QA, and Radhakrishna Tirumalai, Sr. Principal Scientist at Merck Research Laboratories. -
ANSI/PDA Standard on Cryopreservation of Cells for Cell and Gene Therapies Receives Complete Recognition Status by U.S. FDA CBER
The 2021 standard is included in a cohort of standards relevant to regenerative medicine therapies recognized either completely or partially by the Center for Biologics in 2023. -
PDA Announces Collaboration with the U.S. FDA Concerning Services for Pharma Compounders
The collaboration will extend for four years and include expanded training opportunities and an interactive, in-person and virtual interest group for individuals in the outsourcing facility and compounding pharmacy. -
Parenteral Drug Association Announces the 2024 All-Volunteer Officers and Board of Directors
Anil Sawant becomes the Chair for 2024-2025; Melissa Seymour is Chair-Elect; Sue Schniepp becomes Im. Past Chair -
PDA Announces 2023 Drug Delivery Innovation Award Winners at Universe of Pre-Filled Syringes Conference
Merck KGaA wins the Innovation Award, and the Partnership Award is given to Stevanato Group, Bayer US LLC and Vetter Pharma-Fertigung. -
PDA Announces the Jette Christensen Early Career Professional Grant in Memory of Past PDA Chair
PDA today announced the establishment of the Jette Christensen Early Career Professional Grant in memory of the Immediate-Past Chair of the PDA Board of Directors, who passed away on October 24 after a long battle with cancer. -
Parenteral Drug Association Announces Pulitzer Prize Winner Dominic Gates will speak at the 2023 PDA/FDA Joint Regulatory Conference
Gates will address the devastating consequences of quality lapses in the aerospace industry in the second plenary session on Sept. 18. -
PDA Announces Two U.S. FDA Center Directors for Opening and Closing Keynotes at the 2023 PDA/FDA Joint Regulatory Conference
Crowd-favorite sessions like Center and Compliance Office Updates, Current CGMP Compliance Trends and Topics, and Lunch with the Regulators return! -
PDA and Innerspace Partner to Develop Training Courses Using Advanced Virtual Reality Simulators for Global Pharma Industry
The first new PDA/Innerspace training course is called Fundamentals of Aseptic Processing, which will be held in Carlsbad, Calif., in July. -
PDA Announces Three Speakers from the U.S. FDA for ATMP Conference
The three confirmed FDA speakers are all from Center for Biologics Evaluation and Research (CBER) and include: Tiffany Lucas, PhD, Gene Therapy CMC Reviewer; Brenton K. McCright, PhD, Biologist; Mikhail V. Ovanesov, PhD, Branch Chief. -
2023 PDA Annual Meeting: Take Advantage of New Orleans La.
A new feature of the 2023 conference is a “free” night on Tuesday, April 4, to explore all New Orleans, La. has to offer. The Hyatt Regency New Orleans is walking distance to many of the city’s renowned tourist attractions, including the historic French Quarter, Arts District, and Mississippi Riverfront. There’s no better place from which to explore the eclectic vibrancy of New Orleans. -
2023 PDA Annual Meeting Offers Learnings in a Patient-Centric World
The 2023 PDA Annual Meeting, April 3-5, in New Orleans, La., is organized around the theme, “Back to the Future: Learning from The Past in A Patient-Centric World.” The meeting will spotlight the critical connection between our patients and the manufacturing process and enabling a patient-focused mindset on the manufacturing floor. -
Parenteral Drug Association Announces New EU GMP Annex 1 Implementation Interest Group
Industry experts leading the Interest Group will be Marcia Baroni, Emergent BioSolutions, Rebecca Brewer, Quality Executive Partners, Gabriele Gori, Thermo Fisher Scientific, and Stephen Langille, ValSource. -
Parenteral Drug Association and RX Announce Renewal of Premier Association Sponsorship Agreement for INTERPHEX
The Parenteral Drug Association, Inc. (PDA) and RX Global today announced the renewal of their Premier Association Sponsorship agreement for INTERPHEX 2023, taking place April 25-27, 2023, at the Javits Center in New York City. This is the tenth year PDA has served as a Premier Association Supporter. -
PDA Announces the Volunteer Members of its 2023 Board of Directors and Officers
PDA Announces the Volunteer Members of its 2023 Board of Directors and Officers -
PDA Announces 2022 Drug Delivery Innovation Awards Winners
Ascendis A/S and Phillips-Medisize A/S received PDA's Innovation Award for the SKYTROFA® Auto-Injector. The Stevanato Group and Bexson Biomedical earned the the Partnership Innovation Award for the innovation Pain Management Therapy through On-Body Injector System. -
PDA Partners with SmartSkin to Bring New Technology to Aseptic Processing Training
SmartSkin discussed manufacturing and quality assurance issues at the 2022 PDA/FDA Joint Regulatory Conference in Washington earlier this month and showcased its latest product innovations to PDA and FDA members. SmartSkin will also be attending the upcoming PDA Universe of Pre-Filled Syringes and Injection Devices show in Palm Springs, CA, October 18-19. -
PDA Announces Nearly 100 Exhibitors at the 19th Universe of Pre-Filled Syringes and Injection Devices Conference
The largest conference/exhibition dedicated to this critical technology for the delivery of biological and traditional medicines returns to in-person meeting in 2022 -
31st PDA/FDA Joint Regulatory Conference Returns to Renaissance Washington, DC Downtown Hotel
This year’s PDA/FDA Joint Regulatory Conference will emphasize the role of implementing effective quality systems to ensure an ongoing state of control throughout the pharmaceutical product lifecycle by vigilantly managing quality risks. The roles of robust systems, facilities, processes, raw material quality, supplier relationships, industrial modernization, and quality risk management will be emphasized. -
PDA's Glenn E. Wright, To Be Named President & CEO, March 2023; Richard M. Johnson to Retire
Richard M. Johnson concludes an eventful and successful 13-year term at PDA's helm, handing the reins to Glenn E. Wright, PDA COO.